“Lycorine inhibits MDA-MB-231 breast cancer cell proliferation, migration and invasion that are associated with Wnt/β-catenin signaling”, Bangladesh J Pharmacol, vol. 13, no. 2, pp. 192–195, Jun. 2018, doi: 10.3329/bjp.v13i2.36350.